HOPE Therapeutics Launches One-Day Depression Treatment in Florida

Reuters
2025.11.10 13:07
portai
I'm PortAI, I can summarize articles.

HOPE Therapeutics, a subsidiary of NRX Pharmaceuticals, has launched the Ampa One Day (ONE-D) protocol for treating resistant depression at various locations in Florida. This initiative aims to provide patient care for individuals struggling with this condition. The information is generated by AI and should not be considered as financial or legal advice.

HOPE Therapeutics, Inc., a subsidiary of NRX Pharmaceuticals Inc., has initiated patient care for treatment-resistant depression using the Ampa One Day (ONE-D) protocol at multiple locations in Florida. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NRX Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9572192-en) on November 10, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.